HomeOwner SearchCategory Search
Studies on Survival, Effectiveness, and Cost Outcomes of First Line Treatments in Chronic Lymphocytic Leukemia
Visit USCO
hero image
Text Registration
Copyright Title

Studies on Survival, Effectiveness, and Cost Outcomes of First Line Treatments in Chronic Lymphocytic Leukemia

Status

Published

on 30 Jun 2021
Year of Creation
2021
Copyright Claimant
Neda Al Rawashdh
Registration Number
TX0008995245
on 30 Jun 2021

Copyright Summary


The U.S. Copyright record (Registration Number: TX0008995245) dated 30 Jun 2021, pertains to an electronic file (eService) titled "Studies on Survival, Effectiveness, and Cost Outcomes of First Line Treatments in Chronic Lymphocytic Leukemia" created in 2021. The copyright holder is Neda Al Rawashdh, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Neda Al Rawashdh.

Copyright Details


Copyright Claimant
Neda Al Rawashdh

Application Details


Registration Number
TX0008995245
Registration Date
6/30/2021
Year of Creation
2021
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States

Personal Authors


Notes


Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements


Application Title Statement: Studies on Survival, Effectiveness, and Cost Outcomes of First Line Treatments in Chronic Lymphocytic Leukemia
Author Statement: Neda Al Rawashdh Citizenship: not known Authorship: text
Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

© 2024 reserved by Trademarkia
Show terms & conditions